“From her position as a nephrologist and Assistant Director of the Tissue Typing Laboratory at Brigham and Women’s Hospital, Dr. Tinckam joined the University Health Network in 2007 and has held numerous internal and external roles since. In addition to her ongoing clinical and academic work in transplant nephrology, she has served as Co-Director of HLA from 2007-2013, Director of HLA from 2013-2017 and Division Head of HLA from 2017-2020. She was the Director of Quality and Innovation for the UHN (now Ajmera Family) Transplant Program from 2017-2019. She became the Interim Program Medical Director for the Laboratory Medicine Program in 2019.
External to UHN she has also held progressive leadership roles in the National Transplant Program at Canadian Blood Services including Vice Chair of the National HLA Advisory Committee from 2010-2018, a secondment as Medical Advisor in Transplantation (Canadian Transplant Registry) from 2013-2017 and Chair of the Kidney Transplant Advisory Committee from 2017-2020. She has served as an HLA advisor to the Trillium Gift of Life Network since 2010 and has Chaired the Provincial HLA Working Group since 2017. She was a Board Member for the Canadian Society of Transplantation from 2013-2019 and served as its Vice President from 2017-2019.”
Dr. Tinckham’s clinical, administrative, and research activities focus on improving access to transplantation for patients who are difficult to match with donors, and increasing equitable access to transplantation at the regional and national level. In all her work, she is focused on a committed and rigorous approach to transparent quality assurance and improvement with an emphasis on thoughtful process design and implementation to drive system change.